Part 7: Emerging Battlegrounds Cell and Gene Therapy, Trade Secret Thickets, and the Next Frontier Key Takeaways: Part 7 Cell and gene (C&G) therapies CAR-T, gene editing platforms, viral vector-based gene therapy, RNA therapies present a fundamentally different IP challenge than conventional pharmaceuticals
Medicaid coverage of and spending on GLP-1
Symptoms may include severe abdominal pain, nausea, and vomiting
Prolotherapy has been shown to reduce pain and stiffness, and improve knee function and quality of life in knee OA patients
The #uncomfortable #truth This 2026 BMJ systematic review and #metaanalysis delivers one of the clearest reality checks yet on weight regain after stopping weight-management medications (WMMs), including GLP-1 and dual incretin therapies
These measures reduce immediate swelling and discomfort